Brief: Theriva Biologics Implements 32% Workforce Reduction - SEC Filing
02/10/2025 21:26
Oct 2 (Reuters) - Theriva Biologics Inc TOVX.A: THERIVA BIOLOGICS INC - APPROVES PLAN TO RESTRUCTURE COMPANY - SEC FILING THERIVA BIOLOGICS INC - IMPLEMENTS 32% WORKFORCE REDUCTION - SEC FILING THERIVA BIOLOGICS INC: EXPECTS WILL EXTEND ITS CASH RUNWAY INTO Q2 OF 2026 Source text: [ID:n0001104659-25-096047] Further company coverage: TOVX.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theriva Biologics
See all newsTheriva Biologics Q2 net loss narrows on lower R&D costs, expenses
Brief: Theriva™ Biologics Announces Upcoming Presentation Of Additional Data From The Virage Phase 2B Clinical Trial Of Vcn-01 In Metastatic Pancreatic Cancer At Aacr 2026 Annual Meeting
Brief: Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications
Brief: Theriva Biologics Implements 32% Workforce Reduction - SEC Filing
Brief: Theriva™ Biologics Announces Presentation Of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial At Asco 2025